Drug access and affordability

Patients should have access to the medications they need without burdensome costs. That’s why a comprehensive solution across the drug supply chain is needed to preserve access and address rising drug costs.

Dermatologists are committed to providing the most effective and cost-efficient care and pharmaceutical therapies to their patients. A variety of factors have affected patients’ access to treatment, including market forces that have led to consolidation of drug manufacturers, slow approval processes for new generic and specialty drugs and more.

The AADA advocates on a variety of issues to assure that patients have access to the most appropriate treatments.

Learn more about specific access and affordability issues by clicking on the tabs above.